I2O THERAPEUTICS, INC.

Profile

Company Names

I2O THERAPEUTICS, INC.

Addresses

610 MAIN STREET, CAMBRIDGE, MA 02139

700 MAIN STREET, CAMBRIDGE, MA 02139

13250 VIA ARRIBA DRIVE, SARATOGA, CA 95070

Phone Numbers

408-476-1904

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$43,939,921.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-09-18 
$3,500,000.00 
$3,987,042.00 
$487,042.00 
Equity 
5
2022-07-18 
$33,539,921.00 
$42,032,225.00 
$8,492,304.00 
Equity 
4
2021-10-01 
$2,300,000.00 
$3,000,000.00 
$700,000.00 
Debt 
3
2020-11-16 
$600,000.00 
$600,000.00 
$0.00 
Debt 
2
2020-03-13 
$3,200,000.00 
$3,200,000.00 
$0.00 
Debt 
1
2019-06-27 
$800,000.00 
$4,000,000.00 
$3,200,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANTHONY 
 
AIUDI 
DIRECTOR
FOUNT BIO, INC.   |  BIOTHEA PHARMA, INC.   |  NEUTROLIS INC.   |  VALITOR, INC.   |  I2O THERAPEUTICS, INC.   |  ADVANCELL ISOTOPES PTY LTD   |  OTOLITH SOUND, INC.
KATIE 
 
ELLIAS 
DIRECTOR
I2O THERAPEUTICS, INC.   |  VERALOX THERAPEUTICS INC.   |  SAB BIOTHERAPEUTICS, INC.
CHRISTOPHER 
 
GAGLIARDI 
DIRECTOR
I2O THERAPEUTICS, INC.   |  VERALOX THERAPEUTICS INC.
KURT 
 
GRAVES 
DIRECTOR, EXECUTIVE OFFICER
INTARCIA THERAPEUTICS, INC   |  BIOLEX THERAPEUTICS, INC.   |  SPRINGLEAF THERAPEUTICS, INC.   |  RADIUS HEALTH, INC.   |  PULMATRIX INC   |  PULMATRIX OPERATING COMPANY, INC.   |  PULMATRIX, INC.   |  I2O THERAPEUTICS, INC.
MITRAGOTRI 
 
MITRAGOTRI 
EXECUTIVE OFFICER, DIRECTOR
I2O THERAPEUTICS, INC.
SAMIR 
 
MITRAGOTRI 
EXECUTIVE OFFICER, DIRECTOR
LIQUIDX, INC.   |  DX BIOSCIENCES, INC.   |  CAGE BIO, INC.   |  I2O THERAPEUTICS, INC.   |  FOUNT BIO, INC.
RAVI 
 
SRINIVASAN 
EXECUTIVE OFFICER, DIRECTOR
ONCONANO MEDICINE, INC.   |  I2O THERAPEUTICS, INC.   |  CAGE BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-18 
2022-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-18 
2022-01-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-10-01 
2020-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-11-16 
2020-03-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-03-13 
2019-07-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-06-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#